• Rapid Dose Therapeutics, Aavishkar won an Indian patent covering QuickStrip nicotine monolayer oral-film formulations, manufacturing processes.
• Patent No. 599533 granted Aug. 17, 2026, for a 20-year term from the July 22, 2024 filing date.
• Follows a March 2026 Indian grant for QuickStrip nicotine bilayer oral film, expanding IP coverage across multiple product configurations.
• Company positioned the patent as supporting global commercialization plans, including potential licensing or partnership discussions with a nicotine industry leader.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapid Dose Therapeutics Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608200830NEWSFILECNPR____20260820_310585_1) on August 20, 2026, and is solely responsible for the information contained therein.